Literature DB >> 16428436

Conditional knockout mice reveal distinct functions for the global transcriptional coactivators CBP and p300 in T-cell development.

Lawryn H Kasper1, Tomofusa Fukuyama, Michelle A Biesen, Fayçal Boussouar, Caili Tong, Antoine de Pauw, Peter J Murray, Jan M A van Deursen, Paul K Brindle.   

Abstract

The global transcriptional coactivators CREB-binding protein (CBP) and the closely related p300 interact with over 312 proteins, making them among the most heavily connected hubs in the known mammalian protein-protein interactome. It is largely uncertain, however, if these interactions are important in specific cell lineages of adult animals, as homozygous null mutations in either CBP or p300 result in early embryonic lethality in mice. Here we describe a Cre/LoxP conditional p300 null allele (p300flox) that allows for the temporal and tissue-specific inactivation of p300. We used mice carrying p300flox and a CBP conditional knockout allele (CBPflox) in conjunction with an Lck-Cre transgene to delete CBP and p300 starting at the CD4- CD8- double-negative thymocyte stage of T-cell development. Loss of either p300 or CBP led to a decrease in CD4+ CD8+ double-positive thymocytes, but an increase in the percentage of CD8+ single-positive thymocytes seen in CBP mutant mice was not observed in p300 mutants. T cells completely lacking both CBP and p300 did not develop normally and were nonexistent or very rare in the periphery, however. T cells lacking CBP or p300 had reduced tumor necrosis factor alpha gene expression in response to phorbol ester and ionophore, while signal-responsive gene expression in CBP- or p300-deficient macrophages was largely intact. Thus, CBP and p300 each supply a surprising degree of redundant coactivation capacity in T cells and macrophages, although each gene has also unique properties in thymocyte development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16428436      PMCID: PMC1347027          DOI: 10.1128/MCB.26.3.789-809.2006

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  233 in total

1.  Coordination of p300-mediated chromatin remodeling and TRAP/mediator function through coactivator PGC-1alpha.

Authors:  Annika E Wallberg; Soichiro Yamamura; Sohail Malik; Bruce M Spiegelman; Robert G Roeder
Journal:  Mol Cell       Date:  2003-11       Impact factor: 17.970

2.  EID-2, a novel member of the EID family of p300-binding proteins inhibits transactivation by MyoD.

Authors:  Aimin Ji; Diem Dao; Jiexiao Chen; W Robb MacLellan
Journal:  Gene       Date:  2003-10-30       Impact factor: 3.688

3.  Enhancement of nuclear factor-kappa B acetylation by coactivator p300 and HIV-1 Tat proteins.

Authors:  Bansri Furia; Longwen Deng; Kaili Wu; Shanese Baylor; Kylene Kehn; Hong Li; Robert Donnelly; Tim Coleman; Fatah Kashanchi
Journal:  J Biol Chem       Date:  2001-12-05       Impact factor: 5.157

4.  The H1 and H2 regions of the activation domain of herpes simplex virion protein 16 stimulate transcription through distinct molecular mechanisms.

Authors:  Keiko Ikeda; Thomas Stuehler; Michael Meisterernst
Journal:  Genes Cells       Date:  2002-01       Impact factor: 1.891

5.  Role of acetylated human AP-endonuclease (APE1/Ref-1) in regulation of the parathyroid hormone gene.

Authors:  Kishor K Bhakat; Tadahide Izumi; Suk-Hoon Yang; Tapas K Hazra; Sankar Mitra
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

6.  p300 cooperates with Smad3/4 and Runx3 in TGFbeta1-induced IgA isotype expression.

Authors:  Seok-Rae Park; Eun-Kyoung Lee; Byung-Chul Kim; Pyeung-Hyeun Kim
Journal:  Eur J Immunol       Date:  2003-12       Impact factor: 5.532

7.  A protein interaction map of Drosophila melanogaster.

Authors:  L Giot; J S Bader; C Brouwer; A Chaudhuri; B Kuang; Y Li; Y L Hao; C E Ooi; B Godwin; E Vitols; G Vijayadamodar; P Pochart; H Machineni; M Welsh; Y Kong; B Zerhusen; R Malcolm; Z Varrone; A Collis; M Minto; S Burgess; L McDaniel; E Stimpson; F Spriggs; J Williams; K Neurath; N Ioime; M Agee; E Voss; K Furtak; R Renzulli; N Aanensen; S Carrolla; E Bickelhaupt; Y Lazovatsky; A DaSilva; J Zhong; C A Stanyon; R L Finley; K P White; M Braverman; T Jarvie; S Gold; M Leach; J Knight; R A Shimkets; M P McKenna; J Chant; J M Rothberg
Journal:  Science       Date:  2003-11-06       Impact factor: 47.728

8.  SATB1 makes a complex with p300 and represses gp91(phox) promoter activity.

Authors:  Yoshito Fujii; Atsushi Kumatori; Michio Nakamura
Journal:  Microbiol Immunol       Date:  2003       Impact factor: 1.955

9.  The murine G+C-rich promoter binding protein mGPBP is required for promoter-specific transcription.

Authors:  Li-Chung Hsu; Shu Liu; Ferishteh Abedinpour; Robert D Beech; Jill M Lahti; Vincent J Kidd; Jeffrey A Greenspan; Cho-Yau Yeung
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

10.  Nuclear factor I/thyroid transcription factor 1 interactions modulate surfactant protein C transcription.

Authors:  Cindy J Bachurski; Guan Hu Yang; Tracey A Currier; Richard M Gronostajski; Dihua Hong
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

View more
  98 in total

1.  Control of B cell development by the histone H2A deubiquitinase MYSM1.

Authors:  Xiao-Xia Jiang; Quan Nguyen; YuChia Chou; Tao Wang; Vijayalakshmi Nandakumar; Peter Yates; Lindsey Jones; Lifeng Wang; Haejung Won; Hye-Ra Lee; Jae U Jung; Markus Müschen; Xue F Huang; Si-Yi Chen
Journal:  Immunity       Date:  2011-12-08       Impact factor: 31.745

2.  Ras signaling requires dynamic properties of Ets1 for phosphorylation-enhanced binding to coactivator CBP.

Authors:  Mary L Nelson; Hyun-Seo Kang; Gregory M Lee; Adam G Blaszczak; Desmond K W Lau; Lawrence P McIntosh; Barbara J Graves
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-13       Impact factor: 11.205

Review 3.  Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases.

Authors:  David C Bedford; Lawryn H Kasper; Tomofusa Fukuyama; Paul K Brindle
Journal:  Epigenetics       Date:  2010-01-27       Impact factor: 4.528

4.  Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation.

Authors:  Qihuang Jin; Li-Rong Yu; Lifeng Wang; Zhijing Zhang; Lawryn H Kasper; Ji-Eun Lee; Chaochen Wang; Paul K Brindle; Sharon Y R Dent; Kai Ge
Journal:  EMBO J       Date:  2010-12-03       Impact factor: 11.598

5.  Regulation of c-Maf and αA-Crystallin in Ocular Lens by Fibroblast Growth Factor Signaling.

Authors:  Qing Xie; Rebecca McGreal; Raven Harris; Chun Y Gao; Wei Liu; Lixing W Reneker; Linda S Musil; Ales Cvekl
Journal:  J Biol Chem       Date:  2015-12-30       Impact factor: 5.157

6.  p300 is not required for metabolic adaptation to endurance exercise training.

Authors:  Samuel A LaBarge; Christopher W Migdal; Elisa H Buckner; Hiroshi Okuno; Ilya Gertsman; Ben Stocks; Bruce A Barshop; Sarah R Nalbandian; Andrew Philp; Carrie E McCurdy; Simon Schenk
Journal:  FASEB J       Date:  2015-12-28       Impact factor: 5.191

7.  Two histone/protein acetyltransferases, CBP and p300, are indispensable for Foxp3+ T-regulatory cell development and function.

Authors:  Yujie Liu; Liqing Wang; Rongxiang Han; Ulf H Beier; Tatiana Akimova; Tricia Bhatti; Haiyan Xiao; Philip A Cole; Paul K Brindle; Wayne W Hancock
Journal:  Mol Cell Biol       Date:  2014-08-25       Impact factor: 4.272

8.  Genetic heterogeneity in Rubinstein-Taybi syndrome: delineation of the phenotype of the first patients carrying mutations in EP300.

Authors:  Deborah Bartholdi; Jeroen H Roelfsema; Francesco Papadia; Martijn H Breuning; Dunja Niedrist; Raoul C Hennekam; Albert Schinzel; Dorien J M Peters
Journal:  J Med Genet       Date:  2007-01-12       Impact factor: 6.318

9.  Transgenic mice expressing an inhibitory truncated form of p300 exhibit long-term memory deficits.

Authors:  Ana M M Oliveira; Marcelo A Wood; Conor B McDonough; Ted Abel
Journal:  Learn Mem       Date:  2007-08-29       Impact factor: 2.460

10.  p300 Mediates Muscle Wasting in Lewis Lung Carcinoma.

Authors:  Thomas K Sin; James Z Zhu; Guohua Zhang; Yi-Ping Li
Journal:  Cancer Res       Date:  2019-01-31       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.